Fludarabine-melphalan reduced-intensity conditioning matched sibling bone marrow stem cell transplantation is an effective treatment for myeloid disorders

被引：0
作者：
Malladi, R
Peniket, A
Collins, G
Littlewood, T
机构：
[1] John Radcliffe Hosp, Oxford OX3 9DU, England
[2] John Radcliffe Hosp Clin Haematol, Oxford, England
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [31] Oral versus Intravenous Fludarabine as Part of a Reduced-Intensity Conditioning for Allogeneic Stem Cell Transplantation
    Velazquez-Sanchez-de-Cima, Sara
    Zamora-Ortiz, Gabriela
    Hernandez-Reyes, Jesus
    Daniel Rosales-Duron, Alan
    Patricia Gonzalez-Ramirez, Monica
    Angela Martagon-Herrera, Nora
    Ruiz-Delgado, Guillermo J.
    Ruiz-Argueelles, Guillermo J.
    ACTA HAEMATOLOGICA, 2014, 132 (01) : 125 - 128
  • [32] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    R M Sobecks
    R Dean
    L A Rybicki
    J Chan
    K S Theil
    R Macklis
    S Andresen
    M Kalaycio
    B Pohlman
    C Ferraro
    K Cherni
    J Sweetenham
    E Copelan
    B J Bolwell
    Bone Marrow Transplantation, 2008, 42 : 715 - 722
  • [33] Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation
    de Souza, Jonas A.
    Saliba, Rima M.
    Patah, Poliana
    Rondon, Gabriela
    Ribeiro, Rachel
    Silva, Leandro de Padua
    Qazilbash, Muzaffar H.
    Hosing, Chitra
    Popat, Uday
    Efebera, Yvonne
    Champlin, Richard E.
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1094 - 1099
  • [34] Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse
    Imahashi, Nobuhiko
    Ohashi, Haruhiko
    Terakura, Seitaro
    Miyao, Kotaro
    Sakemura, Reona
    Kato, Tomonori
    Sawa, Masashi
    Yokohata, Emi
    Kurahashi, Shingo
    Ozawa, Yukiyasu
    Nishida, Tetsuya
    Kiyoi, Hitoshi
    Watamoto, Koichi
    Kohno, Akio
    Kasai, Masanobu
    Kato, Chiaki
    Iida, Hiroatsu
    Naoe, Tomoki
    Miyamura, Koichi
    Murata, Makoto
    ANNALS OF HEMATOLOGY, 2015, 94 (07) : 1139 - 1148
  • [35] Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse
    Sakemura, R.
    Imahashi, N.
    Ohashi, H.
    Terakura, S.
    Miyao, K.
    Kato, T.
    Sawa, M.
    Yokohata, E.
    Kurahashi, S.
    Ozawa, Y.
    Nishida, T.
    Kiyoi, H.
    Watamoto, K.
    Kohno, A.
    Kasai, M.
    Kato, C.
    Iida, H.
    Naoe, T.
    Miyamura, K.
    Murata, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S453 - S453
  • [36] Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse
    Nobuhiko Imahashi
    Haruhiko Ohashi
    Seitaro Terakura
    Kotaro Miyao
    Reona Sakemura
    Tomonori Kato
    Masashi Sawa
    Emi Yokohata
    Shingo Kurahashi
    Yukiyasu Ozawa
    Tetsuya Nishida
    Hitoshi Kiyoi
    Koichi Watamoto
    Akio Kohno
    Masanobu Kasai
    Chiaki Kato
    Hiroatsu Iida
    Tomoki Naoe
    Koichi Miyamura
    Makoto Murata
    Annals of Hematology, 2015, 94 : 1139 - 1148
  • [37] ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING IN CHRONIC MYELOID LEUKAEMIA
    Morozova, E., V
    Vlasova, Y., I
    Barabanshikova, M., V
    Afanaseva, K. S.
    Iurovskaia, K. S.
    Gindina, T. L.
    Barchatov, I. M.
    Alyanskiy, A. L.
    Bakin, E. A.
    Bondarenko, S. N.
    Moiseev, I. S.
    Zubarovskaya, L. S.
    Afanasyev, B., V
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (04): : 386 - 402
  • [38] Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning
    Koyama, M
    Nakano, T
    Takeshita, Y
    Sakata, A
    Sawada, A
    Yasui, M
    Okamura, T
    Inoue, M
    Kawa, K
    BONE MARROW TRANSPLANTATION, 2005, 36 (05) : 453 - 454
  • [39] Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
    Lekakis, Lazaros
    de Lima, Marcos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 785 - 798
  • [40] Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan
    Oran, Betul
    Giralt, Sergio
    Saliba, Rima
    Hosing, Chitra
    Popat, Uday
    Khouri, Issa
    Couriel, Daniel
    Qazilbash, Muzaffar
    Anderlini, Paolo
    Kebriaei, Partow
    Ghosh, Shubhra
    Carrasco-Yalan, Antonio
    de Meis, Ernesto
    Anagnostopoulos, Athanasios
    Donato, Michele
    Champlin, Richard E.
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (04) : 454 - 462
12345